|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1992; 19:918-925 © 1992 by the American College of Cardiology Foundation |
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.
Impaired endothelial-dependent vasodilation has been demonstrated in two animal models of congestive heart failure and in the coronary circulation of patients with idiopathic dilated cardiomyopathy. To determine whether this impairment contributes to the abnormal peripheral vasomotor tone in patients with congestive heart failure, the local vascular response to intraarterial infusions of graded concentrations (10(-8) M to 10(-5) M) of acetylcholine (an endothelial-dependent vasodilator) and nitroglycerin (a direct-acting vasodilator) was studied in the superficial femoral artery of 19 patients with congestive heart failure (New York Heart Association classes I to IV) and 6 age-matched normal control subjects. The local vascular response was determined from the arterial blood flow velocity pattern obtained by transcutaneous Doppler ultrasonography. Acetylcholine, 10(-5) M, induced a pattern characteristic of vasodilation in all six normal subjects; mean blood flow velocity for the group significantly increased from 11.9 +/- 2.7 to 44.8 +/- 20.9 cm/s (p less than 0.05). In contrast, the same dose of acetylcholine induced a blood flow velocity pattern characteristic of vasodilation in only 4 of the 19 patients with congestive heart failure. Group mean blood flow velocity did not change significantly. Nitroglycerin, 10(-7) M, induced vasodilation in all 6 normal subjects but in only 1 of 19 patients. Nitroglycerin, 10(-5) M, was administered to 10 patients; all 10 demonstrated a pattern characteristic of vasodilation. Thus, acetylcholine-mediated endothelial-dependent vasodilation appears to be impaired in the peripheral vasculature of patients with congestive heart failure. Both endothelial dysfunction and abnormal vascular smooth muscle responsiveness may contribute to abnormal peripheral vasomotor tone.
This article has been cited by other articles:
|
|
 |
|
  E. M. F. Van Craenenbroeck, C. J. Vrints, S. E. Haine, K. Vermeulen, I. Goovaerts, V. F. I. Van Tendeloo, V. Y. Hoymans, and V. M. A. Conraads A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile J Appl Physiol, April 1, 2008; 104(4): 1006 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Boos, S. K. Soor, D. Kang, and G. Y.H. Lip Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes Eur. Heart J., May 1, 2007; 28(9): 1092 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Hundley, E. Bayram, C. A. Hamilton, E. A. Hamilton, T. M. Morgan, S. N. Darty, K. P. Stewart, K. M. Link, D. M. Herrington, and D. W. Kitzman Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1427 - H1434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Baumhakel, N. Werner, M. Bohm, and G. Nickenig Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease Eur. Heart J., September 2, 2006; 27(18): 2184 - 2188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Blankfield Can Natriuretic Peptide Levels Predict the Cardiovascular Complications of COX-2 Inhibitors and Nonsteroidal Anti-inflammatory Drugs? J Am Board Fam Med, March 1, 2006; 19(2): 178 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Green, A. J. Maiorana, J. H. J. Siong, V. Burke, M. Erickson, C. T. Minson, W. Bilsborough, and G. O'Driscoll Impaired skin blood flow response to environmental heating in chronic heart failure Eur. Heart J., February 1, 2006; 27(3): 338 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Willoughby, S. Stewart, A. S. Holmes, Y. Y. Chirkov, and J. D. Horowitz Platelet Nitric Oxide Responsiveness: A Novel Prognostic Marker in Acute Coronary Syndromes Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2661 - 2666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Tschakovsky and K. E. Pyke Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial function J Appl Physiol, September 1, 2005; 99(3): 1235 - 1237. [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Katz, K. Hryniewicz, I. Hriljac, K. Balidemaj, C. Dimayuga, A. Hudaihed, and A. Yasskiy Vascular Endothelial Dysfunction and Mortality Risk in Patients With Chronic Heart Failure Circulation, January 25, 2005; 111(3): 310 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Colombo, J. E. Banchs, S. Celaj, A. Talreja, J. Lachmann, S. Malla, N. B. DuBois, A. W. Ashton, F. Latif, U. P. Jorde, et al. Endothelial Cell Activation in Patients With Decompensated Heart Failure Circulation, January 4, 2005; 111(1): 58 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor Effect of exercise training on endothelium-derived nitric oxide function in humans J. Physiol., November 15, 2004; 561(1): 1 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Elkayam, F. Bitar, M. W. Akhter, S. Khan, S. Patrus, and M. Derakhshani Intravenous Nitroglycerin in the Treatment of Decompensated Heart Failure: Potential Benefits and Limitations Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2004; 9(4): 227 - 241. [Abstract] [PDF]
|
|
|
|
 |
|
 S. M. Karim, A. Y. Rhee, A. M. Given, M. D. Faulx, B. D. Hoit, and F. V. Brozovich Vascular Reactivity in Heart Failure: Role of Myosin Light Chain Phosphatase Circ. Res., September 17, 2004; 95(6): 612 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Widder, T. Behr, D. Fraccarollo, K. Hu, P. Galuppo, P. Tas, C. E Angermann, G. Ertl, and J. Bauersachs Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent Cardiovasc Res, July 1, 2004; 63(1): 161 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Thai, J. Wollmuth, S. Goldman, and M. Gaballa Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2 Receptor J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1171 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Linz, G. Itter, L. W Dobrucki, T. Malinski, and G. Wiemer Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 180 - 185. [Abstract] [PDF]
|
|
|
|
|
|
A. Schafer, D. Fraccarollo, S. K Hildemann, P. Tas, G. Ertl, and J. Bauersachs Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction Cardiovasc Res, June 1, 2003; 58(3): 655 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Piccirillo, M. Nocco, A. Moise, M. Lionetti, C. Naso, S. di Carlo, and V. Marigliano Influence of Vitamin C on Baroreflex Sensitivity in Chronic Heart Failure Hypertension, June 1, 2003; 41(6): 1240 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Belhassen, G. Pelle, J.-L. Dubois-Rande, and S. Adnot Improved endothelial function by the thromboxane a2 receptor antagonist s 18886 in patients with coronary artery disease treated with aspirin J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1198 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-Y. Chong, A.D. Blann, and G.Y.H. Lip Assessment of endothelial damage and dysfunction: observations in relation to heart failure QJM, April 1, 2003; 96(4): 253 - 267. [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakamura, H. Yoshida, Y. Naganuma, H. Kon, S. Sugawara, and K. Hiramori Peripheral Vasodilatory Dysfunction in Adult Patients with Congenital Heart Disease and Severely Elevated Pulmonary Vascular Resistance Angiology, November 1, 2002; 53(6): 715 - 720. [Abstract] [PDF]
|
|
|
|
|
|
U. Landmesser and H. Drexler Allopurinol and Endothelial Function in Heart Failure: Future or Fantasy? Circulation, July 9, 2002; 106(2): 173 - 175. [Full Text] [PDF]
|
|
|
|
|
|
D. B. Haitsma, D. Merkus, J. Vermeulen, P. D. Verdouw, and D. J. Duncker Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2198 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kihara, S. Biro, M. Imamura, S. Yoshifuku, K. Takasaki, Y. Ikeda, Y. Otuji, S. Minagoe, Y. Toyama, and C. Tei Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure J. Am. Coll. Cardiol., March 6, 2002; 39(5): 754 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Colombo, A. W. Ashton, S. Celaj, A. Talreja, J. E. Banchs, N. B. Dubois, M. Marinaccio, S. Malla, J. Lachmann, J. A. Ware, et al. Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium J Appl Physiol, March 1, 2002; 92(3): 1331 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Hijmering, E. S. G. Stroes, J. Olijhoek, B. A. Hutten, P. J. Blankestijn, and T. J. Rabelink Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation J. Am. Coll. Cardiol., February 20, 2002; 39(4): 683 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Berghoff, M. Kathpal, S. Kilo, M. J. Hilz, and R. Freeman Vascular and neural mechanisms of ACh-mediated vasodilation in the forearm cutaneous microcirculation J Appl Physiol, February 1, 2002; 92(2): 780 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. F. Mitchell, J.-C. Tardif, J. M. O. Arnold, G. Marchiori, T. X. O'Brien, M. E. Dunlap, and M. A. Pfeffer Pulsatile Hemodynamics in Congestive Heart Failure Hypertension, December 1, 2001; 38(6): 1433 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rossig, J. Hoffmann, B. Hugel, Z. Mallat, A. Haase, J.-M. Freyssinet, A. Tedgui, A. Aicher, A. M. Zeiher, and S. Dimmeler Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure Circulation, October 30, 2001; 104(18): 2182 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Y. Chirkov, A. S. Holmes, S. R. Willoughby, S. Stewart, R. D. Wuttke, P. R. Sage, and J. D. Horowitz Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1851 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Nightingale, D. J. Blackman, G. R. Ellis, M. Schmitt, J. A. Morris-Thurgood, E. A. Jones, and M. P. Frenneaux Preservation of venous endothelial function in the forearm venous capacitance bed of patients with chronic heart failure despite arterial endothelial dysfunction J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1062 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Nightingale, P. P. James, J. Morris-Thurgood, F. Harrold, R. Tong, S. K. Jackson, J. R. Cockcroft, and M. P. Frenneaux Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1334 - H1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Patel, J. T. Kuvin, N. G. Pandian, J. J. Smith, J. E. Udelson, M. E. Mendelsohn, M. A. Konstam, and R. H. Karas Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation J. Am. Coll. Cardiol., January 1, 2001; 37(1): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rossig, J. Haendeler, Z. Mallat, B. Hugel, J.-M. Freyssinet, A. Tedgui, S. Dimmeler, and A. M. Zeiher Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2081 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kaye, B. A. Ahlers, D. J. Autelitano, and J. P. F. Chin-Dusting In Vivo and In Vitro Evidence for Impaired Arginine Transport in Human Heart Failure Circulation, November 28, 2000; 102(22): 2707 - 2712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sakata, R. Nawada, K. Ohbayashi, H. Tamekiyo, and H. Yoshida Diffuse and Severe Left Ventricular Dysfunction Induced by Epicardial Coronary Artery Spasm Angiology, October 1, 2000; 51(10): 837 - 847. [Abstract] [PDF]
|
|
|
|
|
|
A. Maiorana, G. O'Driscoll, L. Dembo, C. Cheetham, C. Goodman, R. Taylor, and D. Green Effect of aerobic and resistance exercise training on vascular function in heart failure Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1999 - H2005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Katz, K. Balidemaj, S. Homma, H. Wu, J. Wang, and S. Maybaum Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure J. Am. Coll. Cardiol., September 1, 2000; 36(3): 845 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Negrao, M. A. Hamilton, G. C. Fonarow, A. Hage, J. D. Moriguchi, and H. R. Middlekauff Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H168 - H174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Comini, T. Bachetti, L. Agnoletti, G. Gaia, S. Curello, B. Milanesi, M. Volterrani, G. Parrinello, C. Ceconi, A. Giordano, et al. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-{alpha} Eur. Heart J., October 2, 1999; 20(20): 1503 - 1513. [Abstract] [PDF]
|
|
|
|
|
|
G. Kojda and D. Harrison Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure Cardiovasc Res, August 15, 1999; 43(3): 652 - 671. [Full Text] [PDF]
|
|
|
|
|
|
J. Bauersachs, A. Bouloumie, D. Fraccarollo, K. Hu, R. Busse, and G. Ertl Endothelial Dysfunction in Chronic Myocardial Infarction Despite Increased Vascular Endothelial Nitric Oxide Synthase and Soluble Guanylate Cyclase Expression : Role of Enhanced Vascular Superoxide Production Circulation, July 20, 1999; 100(3): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Varin, P. Mulder, V. Richard, F. Tamion, C. Devaux, J.-P. Henry, F. Lallemand, G. Lerebours, and C. Thuillez Exercise Improves Flow-Mediated Vasodilatation of Skeletal Muscle Arteries in Rats With Chronic Heart Failure : Role of Nitric Oxide, Prostanoids, and Oxidant Stress Circulation, June 8, 1999; 99(22): 2951 - 2957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yasuda, Y. Goto, H. Sumida, T. Noguchi, T. Baba, S. Miyazaki, and H. Nonogi Angiotensin-Converting Enzyme Inhibition Restores Hepatocyte Growth Factor Production in Patients With Congestive Heart Failure Hypertension, June 1, 1999; 33(6): 1374 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Kanaya, M Nakamura, N Kobayashi, and K Hiramori Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure Heart, May 1, 1999; 81(5): 512 - 517. [Abstract] [Full Text]
|
|
|
|
 |
|
 M.-H. Zou, M. Leist, and V. Ullrich Selective Nitration of Prostacyclin Synthase and Defective Vasorelaxation in Atherosclerotic Bovine Coronary Arteries Am. J. Pathol., May 1, 1999; 154(5): 1359 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Johnson, C. Lucas, L. W. Stevenson, and M. A. Creager Effect of intensive therapy for heart failure on the vasodilator response to exercise J. Am. Coll. Cardiol., March 1, 1999; 33(3): 743 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Patel, I. V. Kaplan, R. N. Patni, D. Levy, J. A. Strom, J. Shirani, and T. H. LeJemtel Sustained Improvement in Flow-Mediated Vasodilation After Short-Term Administration of Dobutamine in Patients With Severe Congestive Heart Failure Circulation, January 12, 1999; 99(1): 60 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hambrecht, E. Fiehn, C. Weigl, S. Gielen, C. Hamann, R. Kaiser, J. Yu, V. Adams, J. Niebauer, and G. Schuler Regular Physical Exercise Corrects Endothelial Dysfunction and Improves Exercise Capacity in Patients With Chronic Heart Failure Circulation, December 15, 1998; 98(24): 2709 - 2715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cooper and A. M. Heagerty Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1482 - H1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S M Maguire, A G Nugent, C McGurk, G D Johnston, and D P Nicholls Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent Heart, August 1, 1998; 80(2): 141 - 145. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Mathier, G. A. Rose, M. A. Fifer, M. I. Miyamoto, R. E. Dinsmore, H. H. Castano, G. W. Dec, I. F. Palacios, and M. J. Semigran Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., July 1, 1998; 32(1): 216 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stephens, M. J. Drinkhill, A. S. Hall, S. G. Ball, and A. M. Heagerty Structure and in vitro function of human subcutaneous small arteries in mild heart failure Am J Physiol Cell Physiol, May 1, 1998; 274(5): C1298 - C1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Husain, N. P. Andrews, D. Mulcahy, J. A. Panza, and A. A. Quyyumi Aspirin Improves Endothelial Dysfunction in Atherosclerosis Circulation, March 3, 1998; 97(8): 716 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, G.-H. Yi, M. Knecht, B.-l. Cai, S. Poposkis, M. Packer, and D. Burkhoff Physical Training Alters the Pathogenesis of Pacing-Induced Heart Failure Through Endothelium-Mediated Mechanisms in Awake Dogs Circulation, October 21, 1997; 96(8): 2683 - 2692. [Abstract] [Full Text]
|
|
|
|
|
|
S. D. Katz, J. Yuen, R. Bijou, and T. H. Lejemtel Training improves endothelium-dependent vasodilation in resistance vessels of patients with heart failure J Appl Physiol, May 1, 1997; 82(5): 1488 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Cohn Is There a Role for Endothelin in the Natural History of Heart Failure? Circulation, August 15, 1996; 94(4): 604 - 606. [Full Text]
|
|
|
|
|
|
T. S. Rector, A. J. Bank, K. A. Mullen, L. K. Tschumperlin, R. Sih, K. Pillai, and S. H. Kubo Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Oral L-Arginine in Patients With Heart Failure Circulation, June 15, 1996; 93(12): 2135 - 2141. [Abstract] [Full Text]
|
|
|
|
|
|
M.W. Ramsey, J. Goodfellow, C.J.H. Jones, L.A. Luddington, M.J. Lewis, and A.H. Henderson Endothelial Control of Arterial Distensibility Is Impaired in Chronic Heart Failure Circulation, December 1, 1995; 92(11): 3212 - 3219. [Abstract] [Full Text]
|
|
